<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36910905</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-7156</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of immunology research</Title><ISOAbbreviation>J Immunol Res</ISOAbbreviation></Journal><ArticleTitle>Necrostatin-1 Alleviates Diffuse Pulmonary Haemorrhage by Preventing the Release of NETs via Inhibiting NE/GSDMD Activation in Murine Lupus.</ArticleTitle><Pagination><StartPage>4743975</StartPage><MedlinePgn>4743975</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4743975</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/4743975</ELocationID><Abstract><AbstractText>Diffuse alveolar haemorrhage (DAH) is a rapidly developing condition owing to a lack of effective treatment and resulting in a high mortality rate in systemic lupus erythematosus (SLE). Neutrophil extracellular traps (NETs) contain numerous antigens and proinflammatory substances that directly damage the vascular endothelium and aggravate vascular inflammation, which is considered an important pathogenic factor of DAH in SLE. Therefore, blocking the release of NETs from neutrophils is an important target for the treatment of DAH in SLE. In this study, we investigated whether the inhibition of neutrophils releasing NETs could relieve DAH in SLE. Necrostatin-1 (Nec-1), a small molecule, has been reported to inhibit the release of NETs by neutrophils. In vitro experiments revealed that Nec-1 inhibited alveolar epithelial cell damage by preventing the release of NETs. Furthermore, vivo studies showed that Nec-1 alleviated lupus pulmonary haemorrhage in mice by reducing lung pathology severity, body weight, and serum inflammatory cytokine levels. Mechanistically, Nec-1 prevented NET release by inhibiting neutrophil elastase (NE) activation and N-Gasdermin D (N-GSDMD) expression. Additionally, immunohistochemistry and immunofluorescence findings showed that Nec-1 decreased NE expression in the lung tissues of mice with lupus pulmonary haemorrhage. Thus, NETs released by neutrophils contributed to the pathogenesis of DAH in SLE, and Nec-1 showed protective effects by the inhibition of NET production via the reduction of NE activation and N-GSDMD expression.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Xinai Han et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xinai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shiqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Shujing</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Quanguang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tianyang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shugeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jie</LastName><ForeName>Hongyu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6175-4055</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinhong</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8339-6391</Identifier><AffiliationInfo><Affiliation>Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630 Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Immunol Res</MedlineTA><NlmUniqueID>101627166</NlmUniqueID><ISSNLinking>2314-7156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507699">necrostatin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.37</RegistryNumber><NameOfSubstance UI="D019272">Leukocyte Elastase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065206" MajorTopicYN="Y">Extracellular Traps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019272" MajorTopicYN="N">Leukocyte Elastase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36910905</ArticleId><ArticleId IdType="pmc">PMC9995194</ArticleId><ArticleId IdType="doi">10.1155/2023/4743975</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lara A. R., Schwarz M. I. Diffuse alveolar hemorrhage. Chest . 2010;137(5):1164&#x2013;1171. doi: 10.1378/chest.08-2084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.08-2084</ArticleId><ArticleId IdType="pubmed">20442117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ednalino C., Yip J., Carsons S. E. Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus. Journal of Clinical Rheumatology . 2015;21(6):305&#x2013;310. doi: 10.1097/RHU.0000000000000291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000000291</ArticleId><ArticleId IdType="pubmed">26308350</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Adhoubi N. K., Bystrom J. Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus . 2020;29(4):355&#x2013;363. doi: 10.1177/0961203320903798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320903798</ArticleId><ArticleId IdType="pmc">PMC7436451</ArticleId><ArticleId IdType="pubmed">32036761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood C., Blanco L. P., Purmalek M. M., et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nature Medicine . 2016;22(2):146&#x2013;153. doi: 10.1038/nm.4027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4027</ArticleId><ArticleId IdType="pmc">PMC4742415</ArticleId><ArticleId IdType="pubmed">26779811</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona-Rivera C., Zhao W., Yalavarthi S., Kaplan M. J. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Annals of the Rheumatic Diseases . 2015;74(7):1417&#x2013;1424. doi: 10.1136/annrheumdis-2013-204837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204837</ArticleId><ArticleId IdType="pmc">PMC4143484</ArticleId><ArticleId IdType="pubmed">24570026</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo R., Tu Y., Xie S., et al. A role for receptor-interacting protein kinase-1 in neutrophil extracellular trap formation in patients with systemic lupus erythematosus: a preliminary study. Cellular Physiology and Biochemistry . 2018;45(6):2317&#x2013;2328. doi: 10.1159/000488179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000488179</ArticleId><ArticleId IdType="pubmed">29550813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Tong Y., Liu Y., Hu H. Self-dsDNA in the pathogenesis of systemic lupus erythematosus. Clinical and Experimental Immunology . 2017;191(1):1&#x2013;10. doi: 10.1111/cei.13041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13041</ArticleId><ArticleId IdType="pmc">PMC5721232</ArticleId><ArticleId IdType="pubmed">28836661</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber A., Rousselle A., Becker J. U., von M&#xe4;ssenhausen A., Linkermann A., Kettritz R. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proceedings of the National Academy of Sciences of the United States of America . 2017;114(45):E9618&#x2013;E9625. doi: 10.1073/pnas.1708247114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708247114</ArticleId><ArticleId IdType="pmc">PMC5692554</ArticleId><ArticleId IdType="pubmed">29078325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Yang X., Chatterjee V., Meegan J. E., Beard Jr R. S., Yuan S. Y. Role of neutrophil extracellular traps and vesicles in regulating vascular endothelial permeability. Frontiers in Immunology . 2019;10(10):p. 1037. doi: 10.3389/fimmu.2019.01037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01037</ArticleId><ArticleId IdType="pmc">PMC6520655</ArticleId><ArticleId IdType="pubmed">31143182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrot P. A., Tellier E., Plantureux L., et al. Neutrophil extracellular traps are associated with the pathogenesis of diffuse alveolar hemorrhage in murine lupus. Journal of Autoimmunity . 2019;100:120&#x2013;130. doi: 10.1016/j.jaut.2019.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.03.009</ArticleId><ArticleId IdType="pubmed">30930069</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x105;browska D., Jab&#x142;o&#x144;ska E., Garley M., Sawicka-Powierza J., Nowak K. The phenomenon of neutrophil extracellular traps in vascular diseases. Archivum Immunologiae et Therapiae Experimentalis (Warsz) . 2018;66(4):273&#x2013;281. doi: 10.1007/s00005-018-0505-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-018-0505-y</ArticleId><ArticleId IdType="pmc">PMC6061175</ArticleId><ArticleId IdType="pubmed">29404659</ArticleId></ArticleIdList></Reference><Reference><Citation>Porto B. N., Stein R. T. Neutrophil extracellular traps in pulmonary diseases: too much of a good thing? Frontiers in Immunology . 2016;7(7):p. 311. doi: 10.3389/fimmu.2016.00311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00311</ArticleId><ArticleId IdType="pmc">PMC4983612</ArticleId><ArticleId IdType="pubmed">27574522</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A., Crofford L. J., Oates J. C. At the bedside: neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. Journal of Leukocyte Biology . 2016;99(2):265&#x2013;278. doi: 10.1189/jlb.5BT0615-234R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.5BT0615-234R</ArticleId><ArticleId IdType="pmc">PMC6608010</ArticleId><ArticleId IdType="pubmed">26658004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutua V., Gershwin L. J. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clinical Reviews in Allergy and Immunology . 2021;61(2):194&#x2013;211. doi: 10.1007/s12016-020-08804-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08804-7</ArticleId><ArticleId IdType="pmc">PMC7395212</ArticleId><ArticleId IdType="pubmed">32740860</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Ma Y., Opsomer G., Pascottini O. B., Guan Y., Dong Q. Neutrophil extracellular traps in cattle health and disease. Research in Veterinary Science . 2021;139:4&#x2013;10. doi: 10.1016/j.rvsc.2021.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rvsc.2021.06.019</ArticleId><ArticleId IdType="pubmed">34217982</ArticleId></ArticleIdList></Reference><Reference><Citation>De Meo M. L., Spicer J. D. The role of neutrophil extracellular traps in cancer progression and metastasis. Seminars in Immunology . 2021;57, article 101595 doi: 10.1016/j.smim.2022.101595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2022.101595</ArticleId><ArticleId IdType="pubmed">35125298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravindran M., Khan M. A., Palaniyar N. Neutrophil extracellular trap formation: physiology, pathology, and pharmacology. Biomolecules . 2019;9(8):p. 365. doi: 10.3390/biom9080365.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9080365</ArticleId><ArticleId IdType="pmc">PMC6722781</ArticleId><ArticleId IdType="pubmed">31416173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kummarapurugu A. B., Zheng S., Ma J., Ghosh S., Hawkridge A., Voynow J. A. Neutrophil elastase triggers the release of macrophage extracellular traps: relevance to cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology . 2022;66(1):76&#x2013;85. doi: 10.1165/rcmb.2020-0410OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0410OC</ArticleId><ArticleId IdType="pmc">PMC8803356</ArticleId><ArticleId IdType="pubmed">34597246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprenkeler E. G. G., Tool A. T. J., Henriet S. S. V., van Bruggen R., Kuijpers T. W. Formation of neutrophil extracellular traps requires actin cytoskeleton rearrangements. Blood . 2022;139(21):3166&#x2013;3180. doi: 10.1182/blood.2021013565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021013565</ArticleId><ArticleId IdType="pubmed">35030250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollberger G., Choidas A., Burn G. L., et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Science Immunology . 2018;3(26) doi: 10.1126/sciimmunol.aar6689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aar6689</ArticleId><ArticleId IdType="pubmed">30143555</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X. A., Jie H. Y., Wang J. H., et al. Necrostatin-1 ameliorates neutrophilic inflammation in asthma by suppressing MLKL phosphorylation to inhibiting NETs release. Frontiers in Immunology . 2020;11(11):p. 666. doi: 10.3389/fimmu.2020.00666.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00666</ArticleId><ArticleId IdType="pmc">PMC7194114</ArticleId><ArticleId IdType="pubmed">32391007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Wang S., Zheng S., Zhang Z., Xu S. Chlorpyrifos suppresses neutrophil extracellular traps in carp by promoting necroptosis and inhibiting respiratory burst caused by the PKC/MAPK pathway. Oxidative Medicine and Cellular Longevity . 2019;2019:11. doi: 10.1155/2019/1763589.1763589</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1763589</ArticleId><ArticleId IdType="pmc">PMC6383406</ArticleId><ArticleId IdType="pubmed">30881588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlenberg J. M., Kaplan M. J. The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? Current Opinion in Rheumatology . 2014;26(5):475&#x2013;481. doi: 10.1097/BOR.0000000000000088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000088</ArticleId><ArticleId IdType="pmc">PMC4153426</ArticleId><ArticleId IdType="pubmed">24992143</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambas K., Mitroulis I., Ritis K. The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Frontiers in Immunology . 2012;3(3):p. 385. doi: 10.3389/fimmu.2012.00385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00385</ArticleId><ArticleId IdType="pmc">PMC3524512</ArticleId><ArticleId IdType="pubmed">23264778</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangou E., Chrysanthopoulou A., Mitsios A., et al. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A) Annals of the Rheumatic Diseases . 2019;78(2):238&#x2013;248. doi: 10.1136/annrheumdis-2018-213181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-213181</ArticleId><ArticleId IdType="pmc">PMC6352428</ArticleId><ArticleId IdType="pubmed">30563869</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X., Guo R., Fan C., et al. RIPK1 downregulation enhances neutrophil extracellular traps in psoriasis. Advances in Dermatology and Allergology . 2022;39(1):81&#x2013;87. doi: 10.5114/ada.2022.113803.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ada.2022.113803</ArticleId><ArticleId IdType="pmc">PMC8953862</ArticleId><ArticleId IdType="pubmed">35369615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary V. R., Grande J. P., Luthra H. S., David C. S. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of pristane-induced lupus. Rheumatology . 2007;46(9):1405&#x2013;1410. doi: 10.1093/rheumatology/kem117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem117</ArticleId><ArticleId IdType="pubmed">17576695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W. Y., Zhang Y. H., Zhang Y. S., et al. Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice. Immunology Letters . 2021;231:49&#x2013;60. doi: 10.1016/j.imlet.2020.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2020.12.012</ArticleId><ArticleId IdType="pubmed">33428991</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang H., Han S., Lu L., Reeves W. H. Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus. Clinical Immunology . 2021;229, article 108764 doi: 10.1016/j.clim.2021.108764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108764</ArticleId><ArticleId IdType="pubmed">34089860</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L., Mu W. Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications. Pharmacological Research . 2021;163, article 105297 doi: 10.1016/j.phrs.2020.105297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105297</ArticleId><ArticleId IdType="pmc">PMC7962892</ArticleId><ArticleId IdType="pubmed">33181319</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P. T., Xue X. D., Zhao Z. D., Lu J. Y., Xie P. L. Necrostatin-1, RIP1/RIP3 inhibitor, relieves transforming growth factor &#x3b2;-induced wound-healing process in formation of hypertrophic scars. Journal of Cosmetic Dermatology . 2021;20(8):2612&#x2013;2618. doi: 10.1111/jocd.13860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocd.13860</ArticleId><ArticleId IdType="pubmed">33237588</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai J., Kumar S. V., Mulay S. R., et al. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. European Journal of Immunology . 2016;46(1):223&#x2013;229. doi: 10.1002/eji.201545605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545605</ArticleId><ArticleId IdType="pubmed">26531064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambara H., Liu F., Zhang X., et al. Gasdermin D exerts anti-inflammatory effects by promoting neutrophil death. Cell Reports . 2018;22(11):2924&#x2013;2936. doi: 10.1016/j.celrep.2018.02.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.067</ArticleId><ArticleId IdType="pmc">PMC5878047</ArticleId><ArticleId IdType="pubmed">29539421</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K. W., Monteleone M., Boucher D., et al. Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps. Science Immunology . 2018;3(26) doi: 10.1126/sciimmunol.aar6676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aar6676</ArticleId><ArticleId IdType="pubmed">30143554</ArticleId></ArticleIdList></Reference><Reference><Citation>Spel L., Martinon F. Gasdermin D opens the way for NETs. Nature Reviews Rheumatology . 2018;14(12):690&#x2013;692. doi: 10.1038/s41584-018-0124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-018-0124-3</ArticleId><ArticleId IdType="pubmed">30425332</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgener S. S., Leborgne N. G. F., Snipas S. J., Salvesen G. S., Bird P. I., Benarafa C. Cathepsin G inhibition by Serpinb1 and Serpinb6 prevents programmed necrosis in neutrophils and monocytes and reduces GSDMD-driven inflammation. Cell Reports . 2019;27(12):3646&#x2013;3656.e5. doi: 10.1016/j.celrep.2019.05.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.065</ArticleId><ArticleId IdType="pmc">PMC7350907</ArticleId><ArticleId IdType="pubmed">31216481</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>